<DOC>
	<DOCNO>NCT00770783</DOCNO>
	<brief_summary>The investigator intend test single center , clinical pilot efficacy study primary hypothesis Magnetic Seizure Therapy ( MST ) add-on therapy control pharmacotherapy efficacious treatment refractory major depression assess Hamilton Depression Rating Scale ( HAMD ) .</brief_summary>
	<brief_title>Magnetic Seizure Therapy ( MST ) Treatment Resistant Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Patient diagnose major depressive episode ( MDE ) accord DSMIV Diagnosis Criteria derive SCID . Patient acceptable clinical response due failure ( resistance ) least two treatment different treatment category current MDE . Patient score â‰¥ 20 24item Hamilton Rating Scale Depression . Patient able give inform consent participate study able fulfill requirement study . Patient male nonpregnant female adequately protected conception . Females childbearing potential must use acceptable method birth control . Convulsive therapy clinically indicated Patient currently secondary diagnosis , sign , delirium , dementia , amnesia , cognitive disorder per DSMIV . Patient currently diagnosis nonaffective psychotic disorder per DSMIV . Patient alcohol substance dependence within previous 12 month abuse within previous six month nicotine dependence abuse . Patient history diagnosis clinically relevant cardiac disease . Patient history diagnosis clinically relevant injury disease central nervous system . Patient magnetic material head . Patient implant medical device cardiac pacemaker , vagus nerve stimulator , medical pump etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>